CYP2C9 and hepatocellular carcinoma: The results showed that the expressions of EIF2B4, EZH2, SRXN1, and LOX were upregulated in most HCC cell lines, and the expressions of CYP2C9 was downregulated, which was consistent with gene expressions in the TCGA database (Figure 10E–I).